Bank of New York Mellon Corp Takes Position in TriMas Corporation $TRS

Key Points

• Bank of New York Mellon acquired 365,929 TriMas shares in the second quarter, worth approximately $16.5 million and representing about 1.02% of the company. Institutional investors collectively own 99.42% of TriMas.
• TriMas reported quarterly EPS of $0.52, beating estimates of $0.49, although revenue fell 36.5% year over year to $174.6 million. The company guided to fiscal 2026 EPS of $1.60–$1.70.
• Shares opened at $38.78, below the analyst consensus price target of $41.50; analysts maintain a “Moderate Buy” consensus. TriMas also pays a quarterly dividend of $0.04 per share, yielding approximately 0.4%.

Bank of New York Mellon Corp acquired a new position in shares of TriMas Corporation (NASDAQ:TRS - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 365,929 shares of the industrial products company's stock, valued at approximately $16,478,000. Bank of New York Mellon Corp owned about 1.02% of TriMas as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Jefferies Financial Group Inc. acquired a new stake in TriMas in the 4th quarter worth $55,036,000. Permian Investment Partners LP acquired a new position in shares of TriMas during the fourth quarter valued at about $29,192,000. SG Americas Securities LLC lifted its stake in shares of TriMas by 688.2% in the first quarter. SG Americas Securities LLC now owns 667,091 shares of the industrial products company's stock valued at $23,975,000 after buying an additional 582,452 shares during the period. Alberta Investment Management Corp bought a new stake in shares of TriMas in the fourth quarter valued at about $16,605,000. Finally, Advisory Research Inc. grew its position in TriMas by 46.0% during the fourth quarter. Advisory Research Inc. now owns 1,096,013 shares of the industrial products company's stock worth $38,854,000 after buying an additional 345,425 shares in the last quarter. Institutional investors own 99.42% of the company's stock.

TriMas Stock Down 1.9%

TRS opened at $38.78 on Tuesday. The firm has a market cap of $1.39 billion, a price-to-earnings ratio of 1.61 and a beta of 0.60. The company has a debt-to-equity ratio of 0.28, a quick ratio of 5.03 and a current ratio of 5.44. The firm's 50-day simple moving average is $40.62 and its 200-day simple moving average is $39.12. TriMas Corporation has a twelve month low of $30.43 and a twelve month high of $45.42.

TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The industrial products company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.03. The firm had revenue of $174.58 million during the quarter, compared to the consensus estimate of $178.44 million. TriMas had a net margin of 104.22% and a return on equity of 6.41%. The firm's quarterly revenue was down 36.5% on a year-over-year basis. During the same period last year, the firm posted $0.61 EPS. TriMas has set its FY 2026 guidance at 1.600-1.700 EPS. Equities research analysts anticipate that TriMas Corporation will post 1.67 EPS for the current fiscal year.

TriMas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 13th. Stockholders of record on Thursday, August 6th were paid a $0.04 dividend. The ex-dividend date was Thursday, August 6th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. TriMas's payout ratio is 0.67%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on TRS shares. BWS Financial reaffirmed a "buy" rating and issued a $45.00 price target on shares of TriMas in a report on Monday, August 3rd. Wall Street Zen raised TriMas from a "sell" rating to a "hold" rating in a report on Saturday. Zacks Research upgraded TriMas from a "strong sell" rating to a "hold" rating in a research report on Tuesday, May 5th. Finally, Weiss Ratings cut TriMas from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, August 18th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, TriMas presently has a consensus rating of "Moderate Buy" and an average price target of $41.50.

Insider Activity at TriMas

In other news, Director Herbert K. Parker sold 15,000 shares of the business's stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $45.03, for a total value of $675,450.00. Following the transaction, the director directly owned 57,762 shares of the company's stock, valued at $2,601,022.86. The trade was a 20.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 17.50% of the stock is owned by insiders.

TriMas Profile

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source